SANA News and Press, Sana Biotechnology Inc. From 02/13/24

Transplant of HIP-modified pancreatic islet cells provided lasting glucose control in a fully immunocompetent non-human primate (NHP), enabling the achievement of exogenous insulin independence without immunosuppression for six month study duration Administration of anti-CD47 antibody a...

SEATTLE, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (Nasdaq: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it has closed its underwritten upsized public offering of 21,772,728 shares of its common stock, which include...

2024-02-08 06:02:13 ET More on Sana Biotechnology Sana Biotechnology: Finally Rewarding Investors, But Not Sufficiently Derisked Sana Biotechnology's One-And-Done Solution For Diabetes Impresses In NHP Model (Rating Upgrade) Sana Biotechnology: SC291 Moving Forward B...

SEATTLE, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (Nasdaq: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it has priced its underwritten upsized public offering of 17,272,728 shares of its common stock at a price to ...

2024-02-07 17:11:22 ET Gainers: Arm Holdings  ( ARM ) +28% . Confluent ( CFLT ) +14% . Blue Bird Corporation ( BLBD ) +14% . Comtech Telecommunications Corp. ( CMTL ) +5% . Red Rock Resorts, Inc. ( RRR ) +5% . Losers: ...

2024-02-07 16:03:34 ET More on Sana Biotechnology Sana Biotechnology: Finally Rewarding Investors, But Not Sufficiently Derisked Sana Biotechnology cools after record-breaking rally Sana Biotechnology hits 52-week high amid rising volumes Read the full arti...

SEATTLE, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (Nasdaq: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it has commenced an underwritten public offering of $125.0 million of shares of its common stock. In addition,...

2024-01-25 11:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-01-17 14:00:00 ET Summary JD Henning discusses his approach to the market and emphasizes the importance of timing and using momentum gauges to avoid major market downturns. Investing vs trading portfolios. Henning advises caution in the current market and suggests focusin...

2024-01-16 14:10:03 ET Summary Demand for weight loss drugs and related stocks is high, with companies like Novo Nordisk and Eli Lilly experiencing significant returns. Omega Therapeutics may be a speculative investment opportunity in the weight loss drug market as it recently ent...